Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC45992 Diallyl Tetrasulfide

    二烯丙基四硫醚,ICD-1585

    An organosulfur compound with diverse biological activities
  3. GC45965 Tolfenamic Acid-d4

    托芬那酸 D4

    An internal standard for the quantification of tolfenamic acid
  4. GC45960 9c(i472)

    15-LOX-1 Inhibitor i472

    A 15-LO-1 inhibitor
  5. GC45944 para-amino-Blebbistatin

    (-)-4'-amino-Blebbistatin, p-amino-Blebbistatin, (S)-4'-amino-Blebbistatin

    A more stable and less phototoxic form of (–)-blebbistatin with enhanced water solubility
  6. GC38868 TRAF-STOP inhibitor 6877002 TRAF-STOP inhibitor 6877002是一种抑制CD40-TRAF6相互作用的选择性抑制剂(TRAF-STOPs)。
  7. GC38864 TL02-59 TL02-59 is an orally active, selective Src-family kinase Fgr inhibitor with an IC50 of 0.03 nM.
  8. GC38863 TK216 TK216 is a potent inhibitor targeting E26 transformation specific (ETS) factors via blocking the protein-protein interaction with RNA helicases. TK216 exhibits antilymphoma activity.
  9. GC38853 Tandutinib hydrochloride

    MLN518 hydrochloride; CT53518 hydrochloride

    An antagonist of PDGFRβ, FLT3, and c-Kit
  10. GC38848 Se-Methylselenocysteine

    L-硒甲基硒代半胱氨酸,Methylselenocysteine; Se-Methylseleno-L-cysteine

    A selenium-containing amino acid
  11. GC38841 RIPK1-IN-4 RIPK1-IN-4 (compound 8) 是一种有效的 II 型激酶受体相互作用蛋白1 (RIP1) 激酶抑制剂,并且与 DL1-out 无活性形式的 RIP1 结合,对于 RIP1 和 ADP-Glo 激酶,IC50 为分别为 16 nM 和 10 nM。
  12. GC38819 ML334

    LH601A

    ML334是一种有效的NRF2细胞渗透性激活剂。
  13. GC38817 Minerval

    2-羟基乳清酸,2-Hydroxyoleic acid; 2-OHOA

    A synthetic monounsaturated hydroxylated fatty acid

  14. GC38812 MD-224 MD-224 是基于蛋白水解定位嵌合体 (PROTAC) 的高效小分子 (MDM2) 降解物。MD-224 在人白血病细胞中,诱导 MDM2 的快速降解 (<1 nM),抑制 RS4;11 细胞生长的 IC50 值为 1.5 nM。MD-224 有可能成为一类新的抗癌剂。
  15. GC38811 Mcl1-IN-8 Mcl1-IN-8 (Compound 8) 是一种具有口服活性的 Mcl-1-PUMA 界面抑制剂,Ki 为 0.3 μM. Mcl1-IN-8 在减少 PUMA 依赖性细胞凋亡方面表现出双重活性,同时在癌细胞中失活 Mcl-1 介导的抗细胞凋亡。
  16. GC38772 DIM-C-pPhOH

    4(二(1H-吲哚-3-基)甲基)苯酚

    A Nur77 antagonist
  17. GC38740 BMS-1001 hydrochloride An inhibitor of the PD-1/PD-L1 interaction
  18. GC45894 Daunorubicin-13C-d3 A neuropeptide with diverse biological activities
  19. GC45829 Troglitazone-d4

    CS-045-d4

    Troglitazone-d4 是氘标记的曲格列酮。 Troglitazone 是一种 PPARγ 激动剂,对人和鼠 PPARγ 受体的 EC50 分别为 550 nM 和 780 nM。
  20. GC45801 Hesperetin-13C-d3 A neuropeptide with diverse biological activities
  21. GC45800 Cytarabine-13C3

    Ara-C-13C3, 1-β-D-Arabinofuranosylcytosine-13C3

    A neuropeptide with diverse biological activities
  22. GC45798 Rhein-13C4

    1,8-二羟基-3-羧基蒽醌

    An internal standard for the quantification of rhein

  23. GC45772 6(5H)-Phenanthridinone

    6(5H)-菲啶酮

    An inhibitor of PARP1 and 2
  24. GC45764 Ciclopirox-d11 (sodium salt)

    HOE 296b-d11

    A neuropeptide with diverse biological activities
  25. GC45758 Paclitaxel octadecanedioate

    1,18-Octadecanedioic Acid-Paclitaxel, ODDA-PTX, PTX-FA18

    A prodrug form of paclitaxel
  26. GC45723 Macitentan-d4

    马其顿D4,ACT-064992-d4

    An internal standard for the quantification of macitentan
  27. GC45719 Gymnemic Acid I

    匙羹藤酸I

    A triterpene glycoside
  28. GC45717 Chlamydocin An HDAC inhibitor
  29. GC45679 Carubicin

    洋红霉素,Carminomycin; Carminomicin I

    An anthracycline with anticancer activity
  30. GC45673 7,8-Dihydroneopterin

    7,8-二氢-D-新蝶呤

    An antioxidant
  31. GC45618 (±)-trans-GK563

    GK563

    A GVIA iPLA2 inhibitor
  32. GC45616 C6 Urea Ceramide

    C6 Ceramide (d18:1/6:0) Urea, Cer(d18:1/6:0) Urea, D-erythro-Urea-C6-Ceramide

    An inhibitor of neutral ceramidase
  33. GC38710 TVB-3166 A FASN inhibitor
  34. GC38683 Benzyl isothiocyanate

    苄基异硫氰酸酯

    Benzyl isothiocyanate (BITC, Benzoylthiocarbimide, Isothiocyanic Acid Benzoyl Ester) is an isothiocyanate originally found in cruciferous vegetables that exhibits immunomodulatory, anti-parasitic, antibiotic, antioxidative, anti-atherosclerotic, anti-angiogenic, anti-metastatic, anticancer chemotherapeutic, and chemopreventive activities.
  35. GC38653 Selumetinib sulfate

    司美替尼硫酸盐,AZD6244 sulfate; ARRY-142886 sulfate

    Selumetinib (AZD6244) 是一种高效选择性的,非 ATP 竞争性的 MEK1/2 抑制剂, 抑制 MEK1 的 IC50 为 14 nM。Selumetinib (AZD6244) 抑制 MEK1/2 磷酸化水平。
  36. GC38620 Dihydrorotenone

    二氢鱼藤酮

    Dihydrorotenone 是一种天然杀虫剂,是一种线粒体 (mitochondrial) 抑制剂。Dihydrorotenone 可能诱发帕金森综合症。Dihydrorotenone 通过触发内质网应激并激活 p38 信号通路来诱导人浆细胞凋亡 (apoptosis)
  37. GC38617 Dihydrokaempferol

    香橙素

    Dihydrokaempferol(Aromadendrin)是一种天然存在的黄酮类化合物,具有清除自由基、抗炎、抗肿瘤等生物活性。
  38. GC38610 Galgravin

    盖尔格拉文

    A lignan with diverse biological activities
  39. GC38609 Rotundic acid

    铁冬青酸

    Rotundic acid (Rutundic acid), a natural compound, exhibit cytotoxic activities toward human hepatocellular carcinoma (HepG2), malignant melanoma (A375), SCLC (NCI-H446), breast cancer (MCF-7), and colon cancer (HT-29) cell lines.RA induces cell cycle arrest, DNA damage, and apoptosis by modulating the AKT/mTOR and MAPK pathways.
  40. GC38606 Glaucocalyxin A

    蓝萼甲素

    Glaucocalyxin A is a biologically active ent-kauranoid diterpenoid isolated from Rabdosia japonica var. glaucocalyx with antitumor and anti-inflammatory activity. Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells.
  41. GC38592 PTC596

    PTC596

    A BMI1 inhibitor
  42. GC38566 Ilexsaponin A

    毛冬青皂苷A

    Ilexsaponin A 是从冬凌草的根中分离出的,通过抗凋亡途径减轻缺血再灌注引起的心肌损伤。Ilexsaponin A 可以减少心肌梗塞的大小,降低 LDH,AST 和 CK-MB 的血清水平,增加细胞活力并抑制缺氧/复氧心肌细胞的凋亡。
  43. GC38564 Deoxypodophyllotoxin

    脱氧鬼臼毒素

    A flavolignan with diverse biological activities
  44. GC38545 Polygalacin D

    远志皂苷D

    Polygalacin D (PGD) 是从桔梗 Platycodon grandiflorum 中分离的具有抗癌和抗增殖特性的生物活性化合物。Polygalacin D 抑制 IAP 蛋白家族的表达,包括存活蛋白,cIAP-1 和 cIAP-2 蛋白,并通过抑制 GSK3β,Akt 的磷酸化和PI3K 的表达来阻断 PI3K/Akt 途径。Polygalacin D 通过 PI3K/Akt 途径诱导凋亡 (apoptosis)。
  45. GC38467 BTdCPU BTdCPU is a potent activator of heme regulated inhibitor kinase (HRI), one of eukaryotic translation initiation factor 2α kinases (eIF2α-kinases).
  46. GC38452 Dehydrotrametenolic acid

    去氢齿孔酸

    Dehydrotrametenolic acid 是从茯苓 (Poria cocos) 的菌核中分离的甾醇。Dehydrotrametenolic acid 通过 caspase-3 途径诱导细胞凋亡。Dehydrotrametenolic acid 具有抗肿瘤活性,抗炎,抗糖尿病作用。
  47. GC38447 Eriosematin Eriosematin 是一种来自 Flemingia philippinensis 的根的化合物,具有抗增殖活性和诱导细胞凋亡的特性。
  48. GC38437 Fangchinoline

    防己诺林碱

    An alkaloid with diverse biological activities
  49. GC38425 Sophoridine

    槐定碱

    A quinolizidine alkaloid with diverse biological activities
  50. GC38419 Cyclovirobuxine D

    黄杨碱

    An alkaloid with diverse biological activities
  51. GC38408 Diosgenin glucoside

    延龄草苷

    A steroidal saponin with diverse biological activities

Items 1151 to 1200 of 2733 total

per page

Set Descending Direction